Morphélin
Morphélin, licence 80051235: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Erfa Canada 2012 Inc.
- NPN or DIN-HM
- 80051235
- Status
- Inactive licence
- Licence date
- 28 May 2014
- Revision date
- 22 January 2015
- Form
- Vaporisateur
- Route of administration
- Sublinguale
- Application type
- Officinale
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| N-acétyl-5-méthoxytryptamine | 1.0 mg | Not calculated |
Non-medicinal ingredients
Sorbate de potassium, Triglyceride Medium Chain Oil, Acide citrique, Aqua, Saveur, Palmitate d'ascorbyle, Poly(sorbate) 80, Sucralose, glycérol
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | minimum: 1.0 Pulvérisateur ; maximum: 10.0 Pulvérisateur | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Helps increase the total sleep time in people suffering from sleep restriction or altered sleep schedule. Helps to prevent and/or reduce the effect of jet lag for people traveling by plane easterly across two or more time zones. Helps to reduce the time it takes to fall asleep in people with delayed sleep phase disorder. Helps re-set the body's sleep-wake cycle.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
No French warning text available in the imported data.
Warnings are available in English on the official record.
Source
Official Health Canada record, licence 80051235
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2015. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.